Literature DB >> 23348733

Old King coal - molecular mechanisms underlying an ancient treatment for atopic eczema.

W H Irwin McLean1, Alan D Irvine.   

Abstract

Traditional remedies for common disorders have been known for centuries, but insight into their mechanism of action is often limited. In this issue of the JCI, Joost Schalkwijk's research group at the Radboud University Nijmegen Medical Centre in The Netherlands advances our understanding of why topical coal tar is an effective treatment for atopic dermatitis (AD), both rationalizing the use of this traditional medicine, and providing the scientific basis for new therapeutic approaches.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23348733      PMCID： PMC3561843          DOI： 10.1172/JCI67438

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  12 in total

Review 1.  Coal tar: past, present and future.

Authors:  Gurvinder P Thami; R Sarkar
Journal:  Clin Exp Dermatol       Date:  2002-03       Impact factor: 3.470

Review 2.  Epidermal CYP2 family cytochromes P450.

Authors:  Liping Du; Susan M G Hoffman; Diane S Keeney
Journal:  Toxicol Appl Pharmacol       Date:  2004-03-15       Impact factor: 4.219

Review 3.  Filaggrin mutations associated with skin and allergic diseases.

Authors:  Alan D Irvine; W H Irwin McLean; Donald Y M Leung
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

Review 4.  An evidence-based review of the efficacy of coal tar preparations in the treatment of psoriasis and atopic dermatitis.

Authors:  Jordan B Slutsky; Richard A F Clark; Alexander A Remedios; Peter A Klein
Journal:  J Drugs Dermatol       Date:  2010-10       Impact factor: 2.114

5.  DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar.

Authors:  J H J Roelofzen; P G M van der Valk; R Godschalk; G Dettbarn; A Seidel; L Golsteijn; R Anzion; K K H Aben; F J van Schooten; L A L M Kiemeney; P T J Scheepers
Journal:  Toxicol Lett       Date:  2011-07-23       Impact factor: 4.372

6.  Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.

Authors:  Ellen H van den Bogaard; Judith G M Bergboer; Mieke Vonk-Bergers; Ivonne M J J van Vlijmen-Willems; Stanleyson V Hato; Pieter G M van der Valk; Jens Michael Schröder; Irma Joosten; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

7.  Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo.

Authors:  G Smith; S H Ibbotson; M M Comrie; R S Dawe; A Bryden; J Ferguson; C R Wolf
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

Review 8.  Advances in atopic dermatitis.

Authors:  Natalija Novak; Donald Y M Leung
Journal:  Curr Opin Immunol       Date:  2011-10-19       Impact factor: 7.486

9.  A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.

Authors:  Padraic G Fallon; Takashi Sasaki; Aileen Sandilands; Linda E Campbell; Sean P Saunders; Niamh E Mangan; John J Callanan; Hiroshi Kawasaki; Aiko Shiohama; Akiharu Kubo; John P Sundberg; Richard B Presland; Philip Fleckman; Nobuyoshi Shimizu; Jun Kudoh; Alan D Irvine; Masayuki Amagai; W H Irwin McLean
Journal:  Nat Genet       Date:  2009-04-06       Impact factor: 38.330

10.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.

Authors:  Colin N A Palmer; Alan D Irvine; Ana Terron-Kwiatkowski; Yiwei Zhao; Haihui Liao; Simon P Lee; David R Goudie; Aileen Sandilands; Linda E Campbell; Frances J D Smith; Gráinne M O'Regan; Rosemarie M Watson; Jo E Cecil; Sherri J Bale; John G Compton; John J DiGiovanna; Philip Fleckman; Sue Lewis-Jones; Gehan Arseculeratne; Ann Sergeant; Colin S Munro; Brahim El Houate; Ken McElreavey; Liselotte B Halkjaer; Hans Bisgaard; Somnath Mukhopadhyay; W H Irwin McLean
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330
View more
  5 in total

1.  [Current developments in dermatopharmacology].

Authors:  Hans F Merk; Johannes Wohlrab
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

Review 2.  [The aryl hydrocarbon receptor as the target structure for new drugs in psoriasis and atopic dermatitis].

Authors:  Hans F Merk
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

3.  Interventions for hand eczema.

Authors:  Wietske Andrea Christoffers; Pieter-Jan Coenraads; Åke Svensson; Thomas L Diepgen; Janine L Dickinson-Blok; Jun Xia; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-04-26

Review 4.  Role of AhR/ARNT system in skin homeostasis.

Authors:  Masutaka Furue; Masakazu Takahara; Takeshi Nakahara; Hiroshi Uchi
Journal:  Arch Dermatol Res       Date:  2014-06-26       Impact factor: 3.017

5.  Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor.

Authors:  Kenjiro Takei; Chikage Mitoma; Akiko Hashimoto-Hachiya; Hiroshi Uchi; Masakazu Takahara; Gaku Tsuji; Makiko Kido-Nakahara; Takeshi Nakahara; Masutaka Furue
Journal:  J Dermatol       Date:  2014-12-06       Impact factor: 4.005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.